Skip to content

Kumamoto University Malignancy and Atheroscrelosis study

Kumamoto University Malignancy and Atheroscrelosis study - KUMA study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028652
Enrollment
1000
Registered
2017-08-20
Start date
2007-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Sponsors

Cardiovacular Medicine, Kumamoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who received percutaneous coronary intervention in our department.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
target lesion revascularization(TLR) within 1-year

Secondary

MeasureTime frame
total cardiovascular event (cardiovascular death, nonfatal myocardial infarction, unstable angina pectoris, TLR, non TLR revascularization and hospitalization for heart failure decompensation). All-cause death

Countries

Japan

Contacts

Public ContactDaisuke Sueta

Kumamoto University Cardiovacular Medicine

sueta-d@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026